trending Market Intelligence /marketintelligence/en/news-insights/trending/SigwKEgl2ege2eiERfNaVw2 content esgSubNav
In This List

Pfizer to sell Colo. facility to CordenPharma

Blog

Insight Weekly: Energy crisis cripples Europe; i-bank incomes rise; US holiday sales outlook

Blog

Japan M&A By the Numbers: Q3 2022

Blog

Insight Weekly: Reviving nuclear power; 2023 outlook for US financials; PE funds fuel EV sector

Blog

Insight Weekly: Energy reforms after midterms; Crisis ends 'age of gas'; bank deposits fall


Pfizer to sell Colo. facility to CordenPharma

Pfizer Inc. is selling its former Hospira Boulder active pharmaceutical ingredients site in Colorado to CordenPharma, a contract development and manufacturing organization.

CordenPharma will also enter into a multiyear supply arrangement with Pfizer.

Hospira Boulder will change its name to CordenPharma Boulder and will be managed by Brian McCudden, CEO of CordenPharma Colorado.

The transaction is expected to close in November.